Navigation Links
Kessler Institute for Rehabilitation Only Hospital in New Jersey to Offer New Bionic Foot to Amputees

SADDLE BROOK, N.J., Aug. 4 /PRNewswire/ -- Kessler Institute for Rehabilitation ( is the only hospital in New Jersey and one of the first rehabilitation centers in the country to offer amputees the new PROPRIO FOOT(R), a prosthesis that provides greater flexibility and mobility to its users. This advanced bionic technology, developed by Ossur, a global leader in orthopedic products, closely replicates the function of a natural foot and enables wearers to walk with a more natural and balanced gait.

This high-tech prosthesis earned its name and positive reviews from patients for its ability to detect where the foot is in space -- proprioception. Utilizing leading-edge sensor technology and artificial intelligence, the foot is able to identify changes in terrain, slopes and stairs and instruct the ankle to flex appropriately. As a result, amputees ( can move about with greater balance, confidence and safety.

"The advances in bionic technology are simply amazing," said Kessler prosthetist Joe Reda, who is among the first technicians in the nation to be certified in the fitting of this device. "Kessler clients who have already received this new PROPRIO FOOT are thrilled. They walk better, move more comfortably and can even sit down and get up more easily. They're also able to wear different types of shoes as the foot can easily be adjusted to varying heel heights without compromising proper alignment."

The foot's anatomically correct response creates a more symmetrical and balanced gait, reducing the need to "hip hike" and load body weight on the sound limb. This puts less strain on the leg, knees, hips and back. "Basically, this new technology enables us to more closely replicate the natural functioning of the lost limb and create a better prosthesis for our amputee clients," continues Reda.

Clients are evaluated by a team of Kessler specialists and fitted for the prosthesis. They are also trained on the proper use and maintenance of the device.

According to Gus Eppinger, Director of Kessler Orthotics & Prosthetics Services (, "the PROPRIO FOOT is one outstanding example of the many advances being made in bionic technology and prosthetic design. Interestingly, while this particular foot is new to the public, the Department of Defense and the Veterans Administration have been using it for some time to benefit servicemen returning from Iraq and Afghanistan, as well as with veterans of past wars. The good news is that it's now available to amputees in our area."

For more information, contact Kessler Orthotic & Prosthetic Services at 201.368.6029 or 973.992.9700 or visit

Contact: Irene Maslowski, 973-226-1494 or

This release was issued through eReleases(TM). For more information, visit

SOURCE Kessler Institute for Rehabilitation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Shareholder Class Action Filed Against Aetna Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
2. Shareholder Class Action Filed Against Medtronic, Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Shareholder Class Action Filed Against Health Management Associates, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
4. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Shareholder Class Action Filed Against NeuroMetrix Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
6. Shareholder Class Action Filed Against Humana Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
7. Shareholder Class Action Filed Against Candela Corporation by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
8. Shareholder Class Action Filed Against WellPoint, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
9. Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan
10. The Henry H. Kessler Foundation Appoints New Vice President for Research and Strengthens Relationship With Current Research Luminary
11. Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
Post Your Comments:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from reveals that behind the tendency to set low expectations ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the placement of ... President of North American Capital Sales at HTG Molecular . , ... the commercialization of the HTG EdgeSeq system and associated reagents in North America. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
Breaking Medicine Technology: